Cancer Genetics, Inc. Soared
Fri, Dec 06, 2019 at 05:30 PM
Cancer Genetics, Inc. (CGIX:NASDAQ) soared at $6.99, representing a gain of 26.9%. The stock got featured on our News Catalysts scanner on Wed 20 Nov 19 at 01:09 PM in the 'BIOTECH' category. From Thu 14 Nov 19, the stock recorded 42.86% Up Days and 40.00% Green Days
The stock spiked on Fri 29 Nov 19 at $9.5 with a volume of 2M+.
About Cancer Genetics, Inc. (CGIX:NASDAQ)
Cancer Genetics Inc is an early-stage diagnostics company which develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient.
Top 10 Gainers:
- The McClatchy Company (MNI:NASDAQ), 37.36%
- Genesco Inc. (GCO:NYSE), 32.27%
- Big Lots, Inc. (BIG:NYSE), 31.58%
- KLX Energy Services Holdings, Inc. (KLXE:NASDAQ), 30.73%
- Wellesley Bancorp, Inc. (WEBK:NASDAQ), 30.34%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 26.86%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 26.6%
- Atlantic American Corporation (AAME:NASDAQ), 26.45%
- DermTech, Inc. (DMTK:NASDAQ), 26.06%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 25%